Synthesis and Evaluation of Starch-Urea-Borate for Controlled Release Application |
K.P.R. CHOWDARY* and M.N. MURALI KRISHNA |
University College of Pharmaceutical Sciences, Andhra University, Visakhapatnam-530 003, India E-mail: profkprc@rediffmail.com |
Abstract The objective of the present investigation is to synthesize starchurea-
borate, a new starch based polymer and to evaluate its application
in controlled release (CR) and in the design of controlled release tablets
of diclofenac and gliclazide. The release retarding efficiency of starchurea-
borate was also compared with that of known polymers. Starchurea-
borate (SUB) polymer was synthesized by gelatinization of starch
in the presence of urea and borax. Matrix tablets of diclofenac (100
mg) and gliclazide (60 mg) were formulated employing starch-ureaborate
polymer in different proportions of drug and polymer and the
tablets were evaluated. With both diclofenac and gliclazide, release from
the formulated matrix tablets was slow and spread over 24 h and depended
on per cent polymer in the tablet. Release was diffusion controlled and
followed zero order kinetics. Non-fickian diffusion was the drug release
mechanism from the formulated tablets. Diclofenac release from matrix
tablets formulated employing 33 % SUB (DF3) and gliclazide release
from matrix tablets formulated employing 50 % SUB (GF4) was similar
to that from the corresponding commercial SR tablets. Starch-urea-borate
polymer was found suitable for the design of oral controlled release
tablets of diclofenac and gliclazide. The order of increasing release
retarding effect with various polymers was ethyl cellulose = guar gum
> SUB > sodium CMC > HPMC. Starch-urea-borate is a better release
retarding polymer than HPMC and sodium CMC for obtaining controlled
release over 24 h. |
Keywords Starch-urea-borate, Controlled release, Diclofenac, Gliclazide, Matrix tablets |
|
View Article
 This work is licensed under a Creative Commons Attribution 4.0 International License.
|
|
|